Small non-coding RNAs regulate a variety of cellular processes including genomic imprinting, chromatin remodeling, replication, transcription, and translation. Here we report small replication-regulating RNAs (srRNAs) that specifically inhibit DNA replication of the human polyomavirus BK (BKV) in vitro and in vivo. srRNAs from FM3A murine mammary tumor cells were enriched by DNA replication assay-guided fractionation and hybridization to the BKV Non-Coding Control Region (NCCR), and synthesized as cDNAs. Selective mutagenesis of the cDNA sequences and their putative targets suggests the inhibition of BKV DNA replication is mediated by srRNAs binding to the viral NCCR, hindering early steps in the initiation of DNA replication. Ectopic expression of srRNAs in human cells inhibited BKV DNA replication in vivo. Additional srRNAs were designed and synthesized that specifically inhibit SV40 DNA replication in vitro. These observations point to novel mechanisms for regulating DNA replication and suggest the design of synthetic agents for inhibiting replication of polyomaviruses and possibly other viruses.
INTRODUCTION
Small non-coding RNAs (ncRNAs) have important roles in eukaryotic gene expression determining developmental processes and growth and differentiation (reviewed in (1, 8, 20, 27, 30, 50) ). In addition, certain ncRNAs (e.g. Y-RNAs) are required for chromosomal DNA replication and proliferation of mammalian cells (5, 23) , however, the mechanisms by which the latter act are not yet understood. Roles for ncRNAs in regulating viral infections of mammalian cells were uncovered with the discovery of virus-and host-encoded RNAs controlling viral gene expression (reviewed in (10, 41) ), and with the recognition that recruitment of the cellular Origin Recognition Complex (ORC) to the viral origin of replication (OriP) by Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) and initiation of EBV DNA replication is RNA-dependent (38) .
BK virus (BKV) infects nearly the entire human population, but generally is innocuous unless viral replication is activated following kidney transplantation and immune suppression, when it may cause Polyomavirus Associated Nephropathy (PVAN) and allograft loss (14, 19) . Polyomavirus DNA replication in vitro and in vivo requires one viral protein, the large T antigen (TAg), with other factors supplied by the host cell (25, 28) . Polyomavirus DNA replication initiates with TAg binding at the viral origin of replication (39, 44) , and recruitment of host factors such as replication protein A (RPA), DNA polymerase α-primase (Pol-primase) and topoisomerase I (2, 45) , followed by Pol-primase catalyzed de novo synthesis of nascent primers for DNA replication. Early initiation products, the nascent DNA primers, are then extended by DNA polymerase δ and proliferating cell nuclear antigen (PCNA) and the loading factor replication factor C on the leading and lagging strands (37, 55) . Although the DNA replication machineries are conserved between primates and rodents, BKV does not replicate in mouse cells as a result of speciesspecific interactions between TAg and cellular Pol-primase, analogous to what has been observed with simian virus 40 (SV40) (26, 28, 31, 32, 42, 49, 53) . In contrast to what was observed with SV40, however, dominant negative factor(s) present in mouse cell extracts act at the BKV origin of replication to inhibit DNA replication, even in an otherwise supportive environment (28, 53) . The studies reported here identify small ncRNAs as being responsible for the observed inhibition of BKV DNA replication by mouse cell extracts. Notably, these small replication-regulating RNAs (srRNAs) can dramatically inhibit BKV DNA replication when ectopically expressed in human cells.
MATERIALS AND METHODS

DNAs
pUC18-based plasmid DNAs with complete viral origins included pOriBKV (containing sequences of the archetype BKV Dik strain) (28) ; pOriSV40 (SV-S strain (42) ), and BKV-mPyV (containing chimeric BKV and murine polyomavirus origins) (28) ).
All DNAs for replication assays were purified with Midiprep kits (Qiagen, Germany). 
Purification of proteins and the inhibitory activities (IAs).
Human recombinant topoisomerase I (48), Pol-primase (43) , RPA (35, 40) , BKV TAg and SV40 TAg (4, 28, 36) were expressed, purified and their concentrations and activities determined as previously described (21) .
To purify IAs of BKV DNA replication extracts from FM3A cells (57) were prepared as previously described (28 
In vitro DNA replication assays
Replication of DNAs in vitro was assayed as previously described (28, 53) 
In vivo DNA replication assays
Human kidney proximal tubular epithelial cells (HK-2 cells) were grown in RPMI-1640 with 10% FBS, seeded in 12-well plates (1 x 10 5 cells/well), and incubated overnight at 37°C. Cells were transfected with expression vector for TAg pCMV-BKTAg (10 ng), template plasmid pOriBKV (10 ng), srRNA expression vectors pU6-mY1/pU6-B-5-1 or empty control vector pUC (200 ng), and pBC plasmid vector (500 ng) as carrier DNA using Fugene HD (Roche) transfection reagent. Replicated template DNA was extracted and analyzed by southern blotting as previously described (28) . Independent assays were performed in triplicate and yielded equivalent results.
Monopolymerase DNA replication assay
The BKV and SV40 monopolymerase replication assay contained 0.25 µg of pOriBKV DNA (28) 
Initiation of replication of BKV DNA
Initiation reactions were performed according to (47, 53) . In detail, the initiation The reaction mixture was spotted on DE81 paper (Whatman), and then unincorporated NTPs were removed by washing six times with 0.5 M Na 2 HPO 4 , twice each with water and ethanol. The incorporation of NMPs was analyzed by scintillation counting.
Unwinding assay
The unwinding of origin containing plasmid DNA was carried as previously described In the initial step, RNA was ligated to an activated miRNA cloning linker containing Ban I restriction site AppCTGTAGGCACCATCAddA (IDT Inc.) in buffer without ATP. RNA greater than 40 nt was purified from the gel. Alternatively RNA was separated from unligated 3'adaptor by using G-50 spin column. Purified RNA was used for 5' adaptor ligation (ATCGTaggcaccugaaa, RNA/DNA version (lowercase RNA). RNA mixture greater than 40 nt was purified as described above. Purified RNA was used for RT-PCR (RT primer ATTGATGGTGCCTAC, PCR primers ATTGATGGTGCCTACAG, ATCGTAGGCACCTGAAA). Following 25 cycles of PCR products were subsequently cloned into pGemT-Easy vector (Promega).
In vitro RNA synthesis
For in vitro RNA synthesis PCR was performed using primers containing T7 or Sp6 promoter sequences. Alternatively predigested plasmid DNA or synthetic oligonucleotide (template single stranded oligonucleotide with annealed promoter sequence containing primer) was used as a template. Template DNA was transcribed using T7 or Sp6 RNA polymerase (Roche). RNA was purified by isopropanol precipitation (1 volume) following acid phenol, phenol/chloroform, and chloroform extraction.
Enrichment of RNAs binding to origin DNA
An RNA pool was produced by in vitro transcription of PCR products of cloned small RNA and then was used for selection of origin-binding species. Denatured RNA (0.5 µg) and 50 ng of denatured BKVori (Dik strain 5031-282) were hybridized at 48 0 C in SELEX buffer. Resulting mixtures were separated in 2% agarose gel and RNA/DNA hybrids were purified from the gel using a gel extraction kit (Sigma) and then subjected to RT-PCR amplification followed by in vitro transcription. The enriched RNA pool was used for the next round of selection. Procedure was repeated up to 12 times. PCR products after enrichment steps 5, 8 and 12 were cloned into pGemT-Easy vector, selected and inserts were sequenced.
RESULTS
Inhibitory activities for BKV replication in mouse cell extracts are small ncRNAs specific for the BKV NCCR
In vitro BKV DNA replication assays using the monopolymerase assay (28) were used to guide biochemical fractionation to purify IAs (28, 53) from mouse FM3A cell extracts. Fractions of all purification were analyzed by SDS PAGE, and after Mono Q chromatography, no specific protein bands (stained with silver) correlated with IAs (data not shown). The Mono Q purified fractions of IA occurred as one single peak whose A254/A280 was approximately two, suggesting that IAs are predominantly comprised of nucleic acids. These fractions were analyzed by agarose gel electrophoresis followed by ethidium bromide staining and were found to contain nucleic acids whose migration on a gel suggests a size of less than 100 nt ( Fig. 1A) .
RNase treatment but not DNase treatment of the fractions with maximal inhibitory activity abolished inhibition of BKV DNA replication in vitro (Fig. 1B) indicating the IA is composed of small RNAs, hereafter called srRNAs. While these findings do not rule out the presence of accessory proteins (such as RNPs), no evidence has been obtained suggesting the requirement for such.
To assess the specificity of the fractionated srRNAs, the highly purified Mono Q fractions were added to monopolymerase replication assays with either BKV or SV40
TAg and DNA containing their cognate NCCRs. These analyses revealed that the inhibition of BKV replication by srRNAs is specific for the BKV NCCR and is independent of the source of TAg (the SV40 TAg can act at the BKV origin (28) 
Enrichment, cloning and sequence analysis of murine srRNAs
The MonoQ-purified small RNAs described in Figure 1A were cloned according to Lau et al. (24) and the recovered plasmids were sequenced. In total 71 cDNA sequences were obtained having an average length of 47±13 nt and an average GC content of 57±10%. These cDNAs were ligated to a T7 promoter and transcribed, and the transcripts tested in various replication assays. One srRNA (Seq3) significantly inhibited BKV replication in the monopolymerase assay and expressing Seq3 in human cells inhibited BKV DNA replication in vivo by about 50%, whereas Seq3 did not inhibit SV40 replication in the monopolymerase assay (summarized in Table 1 and data not shown). Structure predictions using the RNA fold program (http://www.tbi.univie.ac.at/RNA/man/RNAfold.html) suggested that Seq3 contained a hairpin with a ∆G of -10.9 kcal/mol and bioinformatic analyses of Seq3 showed small similarities to origin sequence but did not identify a sequence annotation in published databases (data not shown).
To obtain additional replication inhibitory RNA sequences at a higher frequency than by direct cloning, we developed an alternative strategy involving an adaptation of SELEX (Systematic Evolution of Ligands by EXponential enrichment; (12, 17) Previous observations that templates containing BKV core origins with heterologous cells were reproducibly detected, but in much lower concentrations than those of FM3A cells, and their presence may explain why the total RNA of 293S cells did not stimulate BKV DNA replication or even slightly inhibited replication, whereas HeLa cells, which lack this RNA, stimulated BKV DNA replication (compare Figure 2E with 2D).
Inhibitory srRNAs block BKV DNA replication at an initiation step
To determine whether the unwinding or the initiation reaction is the target for inhibition, these initiation steps were biochemically analyzed. Addition of inhibitory srRNA partially reduced the level of unwound origin DNA (Fig. 4A , summarized in Table 1 ). A slight decrease in unwinding of origin-containing DNA was determined with total FM3A RNA, which was in the range of that observed with B-5-8, but no significant reduction of unwound DNA was determined with B-5-1 and B-8-1 RNA (although both significantly inhibited BKV DNA replication ( Fig. 3A and Table 1 ).
Despite that multiple RNAs including total FM3A RNA reduced unwinding of BKV DNA, the extent of this inhibition (always lower than 15%) cannot solely account for the observed inhibition of viral replication. In contrast to the slight effect on unwinding of BKV origin-containing DNA, the initiation of BKV DNA replication was reproducibly and efficiently inhibited by srRNAs B-5-1 and B-8-1 (Fig. 4B , Table 1 ). In summary, these data reveal that srRNAs can inhibit multiple stages of DNA replication but that the initiation reaction is the main target of the inhibition.
Interactions of srRNAs with BKV NCCR DNA
Previous investigations revealing that sequences flanking the BKV core origin are required for function of the inhibitory activity in FM3A extracts (53) RNA, predicted to hybridize to the BKV NCCR, abolished the ability of RNAs to inhibit the BKV monopolymerase assay (Fig. 5) . Furthermore, RNAs that should bind to the BKV NCCR (e.g. B-5-8(1-17) and B-5-8(37-60)) but that lack a connecting sequence did not inhibit DNA replication (data not shown). Deletions of B-5-1 RNA at the 3'-or 5'-termini did not affect its inhibitory activity, supporting the suggestion that binding sites are situated within the 23-50 nt central region of B-5-1 RNA (Table   1 ). This sequence was synthesized in vitro, and B-5-1(23-50) transcripts were found to exhibit an inhibitory activity equal to that of the parent molecule B-5-1 (Fig. 5B ).
Closer analysis of the B-5-1(23-50) sequence revealed that two sites (underlined nucleotides of B-5-1 and B-5-1 in Table 1 ) should hybridize to the BKV core origin on opposite strands. Introduction of a point mutation into the most 3' site of the two hybridization sequences abolished the inhibition (Fig. 5C, Table 1 , B-5-1(23-50)mut. In contrast, RNA B-5-1(23-50)rc with reverse complementary sequence to B-5-1 , which should hybridize to the reverse complementary sites of the origin DNA (i.e. sites opposite to the original hybridization sites), exhibited inhibitory activity similar to B-5-1 (Fig. 5C ). This suggests that inhibition of replication initiation is mediated by simultaneous binding of one srRNA molecule to opposite strands of the NCCR.
Development of an srRNA that inhibits SV40 DNA replication in vitro B-5-1(23-50) RNA is predicted to have equivalent hybridization sites to the SV40 NCCR, due to the high homology between BKV and SV40. However, the putative SV40 hybridization sites overlap in the RNA sequence, so one RNA molecule would not hybridize to both strands of the SV40 origin at the same time. To examine whether srRNAs inhibitory to SV40 can be developed from this molecule, mutant RNA B-5-1(23-50)SV40 was designed by introducing four nucleotides in the 3' part of the RNA, to create an additional hybridization site for the SV40 core origin (and concomitantly, destroying the hybridization site to the BKV core origin; Fig. 5C , summarized in Table 1 ). In full agreement with the prediction and in contrast to B-5-1(23-50), RNA B-5-1(23-50)SV40 effectively inhibited SV40 but not BKV DNA replication (Fig. 5C , Table 1 ).
De novo design of srRNAs that inhibit BKV DNA replication in vitro
These results indicate that RNAs hybridizing to the upper and lower strand of the BKV or SV40 NCCR, within or close to the core origin, will inhibit DNA replication.
To test this further, we designed RNAs de novo having both hybridization sites within the BKV core origin, or having one site within the core origin and a second site complementary to a sequence 100 nts distant, within the late enhancer sequence.
RNAs D1 and D2, respectively (Fig. 6A, Table 1 ) were synthesized and tested for inhibitory activity. Alternatively the complementary sequences were synthesized in a reverse complementary fashion (Fig. 6A , RNA D3, Table 1 ). All three RNAs also contain a quadruple A stretch to connect the two binding sites. As predicted, these three RNAs significantly inhibited BKV DNA replication in the monopolymerase assay ( Fig. 6B, summarized 
srRNA inhibits BKV DNA replication in vivo
To ascertain if srRNAs function in vivo, the B-5-1 srRNA sequence was placed downstream of the U6 promoter (pU6-B-5-1) and transiently expressed in human kidney tubular epithelial cells (HK-2 cells), together with template DNAs and a DNA expressing BKV TAg. In multiple independent assays, BKV DNA replication was consistently inhibited by up to 70% compared to transfections with the vector DNA (pUC) or the vector expressing an unspecific mouse Y-RNA (pU6-mY1) (Fig. 7) , indicating srRNAs that inhibit the BKV replication in vitro also inhibit BKV DNA replication in vivo.
DISCUSSION
That ncRNAs can control both cellular and viral DNA replication is a significant recent development in our understanding (5, 23, 38) . In prior studies of BKV replication, we discerned the presence of diffusible inhibitors in mouse FM3A cell extracts that had not been detected in similar studies of the replication of other polyomaviruses (28, 53) . Further characterization reveals these inhibitors to be small RNAs, termed srRNAs that are origin-specific and can function both in vitro and in vivo. During our purification we could not detect any specific proteins associated with these srRNAs. Furthermore, inhibition of BKV DNA replication by srRNA was observed in the monopolymerase assay, indicating other accessory proteins are not absolutely required for the inhibition (28, 53) .
It is important to contrast previous studies of RNA aptamers that inhibit the viral helicase (17), with our observations that srRNAs do not inhibit helicase activity of viral TAg. Moreover, the primase activity of Pol-primase itself is not blocked directly by srRNAs, since the same enzyme complex initiates SV40 DNA replication but not BKV DNA replication in the presence of these srRNAs. This is consistent with our previous findings that the inhibitory activities are specific for BKV DNA replication but do not interfere with SV40 DNA replication (28, 53) . However, the de novo synthesis of RNA primers during the initiation of BKV DNA replication by Polprimase may be inhibited by sequence-specific hybridization of the srRNAs.
Bioinformatic analyses of the inhibitory srRNAs suggest that inhibition of BKV DNA replication requires a single molecule of RNA to anneal to both strands of the viral non-coding control region. This leads to the hypothesis that inhibition of replication is mediated by hybridization of srRNAs to sequences on opposite strands close to or within the BKV core-origin so as to form a replication-inactive initiation complex ( Fig. 8) . Interestingly many srRNAs have the feature that just one region of the RNA hybridizes to both strands of the SV40 origin at neighboring sites. Since the SV40 core origin pentamer elements form a more perfect palindrome than the BKV core origin elements, the srRNAs inhibitory for BKV replication do not inhibit SV40 DNA replication. The isolation of identical sequences for both RNAs B-5-1 and B-5-8
suggest that they do not belong to a family of highly repeated genomic sequences, but the identification of genomic sequences encoding these RNAs will require sequencing the FM3A tumor cell genome or deep sequencing of its ncRNAs. The binding of srRNAs to the viral origin DNA is reminiscent of the interaction of antigene RNAs to promoters, but is likely to involve different biochemical mechanisms and pathways, since the argonaute protein is most likely involved in the promoter-dependent inhibition of transcription but not in the action of srRNAs (6, 7, 18, 58) .
The mechanism of inhibition of BKV DNA replication by srRNAs was examined in various ways: deletion mutants of the srRNAs encompassing or exchanging nucleotides within predicted binding sites abolished the inhibition of DNA replication by the srRNAs. In addition, an artificial RNA was designed that specifically inhibits The incorporation of dNMPs into the BKV origin DNA was detected by acid precipitation and scintillation counting. DNA synthesis was determined in duplicates and repeated three times. The average of incorporation of dNMPs and the standard deviations are presented. - Table 1 . 
